EP0000452A1 - 1,2,4-Oxadiazolderivate, ihre Herstellung und Verwendung als Arzneimittel - Google Patents
1,2,4-Oxadiazolderivate, ihre Herstellung und Verwendung als Arzneimittel Download PDFInfo
- Publication number
- EP0000452A1 EP0000452A1 EP78400026A EP78400026A EP0000452A1 EP 0000452 A1 EP0000452 A1 EP 0000452A1 EP 78400026 A EP78400026 A EP 78400026A EP 78400026 A EP78400026 A EP 78400026A EP 0000452 A1 EP0000452 A1 EP 0000452A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- radical
- alkyl
- radicals
- atom
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Definitions
- Certain compounds of the invention form pharmaceutically acceptable acid addition salts; these salts are part of the invention.
- R 1 and R 5 each represent, independently of one another, a chlorine atom, a fluorine atom or the methyl radical.
- the compounds are prepared by reacting a compound of formula II with ammonia or an amine HNR'R "(III), then the intermediate obtained with hydroxylamine.
- the reaction is carried out in a solvent such as a lower alcohol, acetone, benzene, an ether, chloroform, but preferably in methanol.
- a solvent such as a lower alcohol, acetone, benzene, an ether, chloroform, but preferably in methanol.
- the first part of the reaction is carried out in an alkalized mixture of water and acetone, at a temperature ranging from 0 to 10 ° C.
- the second part of the reaction is carried out in a polar solvent, such as an alcohol, in the presence of a tertiary base, without isolation of the intermediate.
- a polar solvent such as an alcohol
- the reaction with the compound (IV) is carried out in a solvent such as an ether, chloroform, a hydrocarbon such as benzene, a lower alcohol, but preferably in chloroform.
- a solvent such as an ether, chloroform, a hydrocarbon such as benzene, a lower alcohol, but preferably in chloroform.
- Example 1 (4-methyl-piperazinyl-1) -3 (2,6-dichloro benzyl) -5 oxadiazole-1,2,4 and its methanesulfonate.
- This compound is dissolved in 300 ml of carbon disulfide and a current of chlorine is passed through the solution under UV irradiation.
- the solvent is removed and the residual oil is distilled under vacuum.
- the product a pale yellow oil, boils at 122-4 ° C / 0.15mmHg.
- the free base is obtained from this salt by addition of 2N sodium hydroxide followed by extraction with methylene chloride. Mp 121.5-122.5 ° C.
- the methanesulfonate melts at 193.7 ° C.
- the solid obtained is crystallized from iso ether p ropylique / isopropanol 70/30. Mp 108.8 ° C.
- the monohydrochloride melts at 257 ° C.
- the crude intermediate is dissolved in 60 ml of ethanol and the solution obtained is added to a suspension of 10.75 g (0.15 mole) of hydroxylamine hydrochloride in 25 ml of pyridine.
- the reaction is slow and very slightly exothermic.
- the reaction is allowed to take place overnight. The temperature generally stabilizes around 40 °.
- the precipitated product is filtered off, then washed with ethanol and ether.
- the filtrate is concentrated to dryness, then taken up in water and made alkaline with 2N sodium hydroxide.
- a second jet of oxadiazole precipitates; it is wrung and washed with ethanol and ether.
- the 3-amino (2,6-dichloro-benzyl) -5 oxadiazole-1, 2, 4 is recrystallized from ethanol, which melts at 185 ° C.
- the following table I shows the compounds of the invention which have been prepared by way of examples according to one of the methods described above.
- the compounds of the invention have been subjected to pharmacological tests which have shown their activity as antihypertensive agents.
- the toxicity of the compounds (I) was determined i.p., in the male CD1 rat (Charles River) weighing 100 to 120 g, kept fasting for 18 hours.
- the lethal dose 50% (LD 50) is shown in Table II.
- Antihypertensive activity is evaluated in spontaneously hypertensive male rats according to the method of Gerold and Tschirky (Arzneim. Forsch. 1968, 18, 1285). Systolic pressure is measured by sensing the pulse at the caudal artery.
- the invention therefore includes all pharmaceutical compositions containing at least one of the compounds (I) as active principle, in combination with any excipients suitable for their administration, mainly by the oral route, but also by the endorectal or parenteral route.
- the daily oral dosage can vary from 4 to 100 mg.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7721447A FR2397408A1 (fr) | 1977-07-12 | 1977-07-12 | Derives d'oxadiazole, leur preparation et leur application en therapeutique |
FR7721447 | 1977-07-12 | ||
FR7817114 | 1978-06-08 | ||
FR7817114A FR2428034A2 (fr) | 1978-06-08 | 1978-06-08 | Derives d'oxadiazole-1,2,4, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0000452A1 true EP0000452A1 (de) | 1979-01-24 |
EP0000452B1 EP0000452B1 (de) | 1981-05-06 |
Family
ID=26220123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP78400026A Expired EP0000452B1 (de) | 1977-07-12 | 1978-06-20 | 1,2,4-Oxadiazolderivate, ihre Herstellung und Verwendung als Arzneimittel |
Country Status (17)
Country | Link |
---|---|
US (2) | US4261994A (de) |
EP (1) | EP0000452B1 (de) |
JP (1) | JPS5834473B2 (de) |
AR (1) | AR222310A1 (de) |
AT (1) | AT362367B (de) |
AU (1) | AU515506B2 (de) |
CA (1) | CA1130806A (de) |
DE (1) | DE2860691D1 (de) |
DK (1) | DK307378A (de) |
ES (2) | ES471609A1 (de) |
FI (1) | FI782220A (de) |
GR (1) | GR64924B (de) |
IL (1) | IL55104A (de) |
IT (1) | IT1096906B (de) |
NO (1) | NO782404L (de) |
NZ (1) | NZ187825A (de) |
PT (1) | PT68267A (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4242352A (en) * | 1977-07-12 | 1980-12-30 | Synthelabo | 3-Amino-5-benzyl-1,2,4-oxadiazoles and anti-hypertensive compositions thereof |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5625877B2 (de) * | 1973-06-19 | 1981-06-15 | ||
US5180731A (en) * | 1986-06-03 | 1993-01-19 | Sumitomo Pharmaceuticals Company, Limited | Aminoazole derivatives and their production and use |
US4914112A (en) * | 1986-06-03 | 1990-04-03 | Sumitomo Pharmaceuticals Company, Limited | Aminoazole derivatives and their production and use |
AT395853B (de) * | 1991-01-31 | 1993-03-25 | Chem Pharm Forsch Gmbh | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung |
WO1993009106A1 (en) * | 1991-10-28 | 1993-05-13 | Tsentr Po Khimii Lekarstvennykh Sredstv | Derivatives of 5-phenoxymethyl-1,2,4-oxadiazol, their salts, method of obtaining them and a pharmaceutical preparation with antihypertensive, antianginal, antiarrhythmic and antiglaucomatomic properties based on them |
ES2184858T3 (es) * | 1995-05-09 | 2003-04-16 | Bayer Cropscience Ag | Cetoenoles alquil-dihalogenofenil substituidos como pesticidas y herbicidas. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2100914A1 (de) * | 1970-07-15 | 1972-03-24 | Squibb & Sons Inc | |
DE2461882A1 (de) * | 1973-12-29 | 1975-07-03 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur herstellung von 3-amino-1,2,4-oxadiazolen |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL302339A (de) * | 1963-03-22 | |||
US3564607A (en) * | 1965-07-30 | 1971-02-16 | Olin Corp | Halogenated aryloxyacetyl cyanamides |
DE1670338A1 (de) * | 1966-03-14 | 1972-08-10 | Heyden Chem Fab | Verfahren zur Herstellung von antimikrobiell wirksamen Nitrofuranderivaten |
FR1559629A (de) * | 1966-09-23 | 1969-03-14 | ||
US3452035A (en) * | 1966-12-23 | 1969-06-24 | American Cyanamid Co | 2 - amino - 5 - (5 - nitro - 1 - substituted-2 - imidazolyl) - 1,3,4 - thiadiazoles and oxadiazoles |
GB1314427A (en) * | 1970-07-17 | 1973-04-26 | Beecham Group Ltd | Amino acid esters of 2,2-dialkyl-4-4-pyridyl-2h-7-substituted- chromen-5-ols |
DE2054342A1 (de) * | 1970-11-05 | 1972-05-10 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Neue 1,2,4-Oxdiazole |
US3879407A (en) * | 1973-02-09 | 1975-04-22 | Johnson & Son Inc S C | 1,2,4-Oxadiazole and thiadiazole esters and compositions containing same |
DE2860691D1 (en) * | 1977-07-12 | 1981-08-13 | Synthelabo | 1,2,4-oxadiazol derivatives, their preparation and application in pharmaceutical compositions |
-
1978
- 1978-06-20 DE DE7878400026T patent/DE2860691D1/de not_active Expired
- 1978-06-20 EP EP78400026A patent/EP0000452B1/de not_active Expired
- 1978-07-07 DK DK783073A patent/DK307378A/da not_active Application Discontinuation
- 1978-07-07 IL IL55104A patent/IL55104A/xx unknown
- 1978-07-07 US US05/922,527 patent/US4261994A/en not_active Expired - Lifetime
- 1978-07-10 AU AU37909/78A patent/AU515506B2/en not_active Expired
- 1978-07-10 NZ NZ187825A patent/NZ187825A/xx unknown
- 1978-07-10 NO NO782404A patent/NO782404L/no unknown
- 1978-07-10 GR GR56739A patent/GR64924B/el unknown
- 1978-07-10 PT PT68267A patent/PT68267A/pt unknown
- 1978-07-10 IT IT25497/78A patent/IT1096906B/it active
- 1978-07-10 CA CA307,090A patent/CA1130806A/en not_active Expired
- 1978-07-11 FI FI782220A patent/FI782220A/fi not_active Application Discontinuation
- 1978-07-11 ES ES471609A patent/ES471609A1/es not_active Expired
- 1978-07-11 JP JP53085017A patent/JPS5834473B2/ja not_active Expired
- 1978-07-12 AT AT505378A patent/AT362367B/de not_active IP Right Cessation
- 1978-07-12 AR AR272930A patent/AR222310A1/es active
-
1979
- 1979-03-12 ES ES478527A patent/ES478527A1/es not_active Expired
- 1979-04-27 US US06/034,197 patent/US4242352A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2100914A1 (de) * | 1970-07-15 | 1972-03-24 | Squibb & Sons Inc | |
DE2461882A1 (de) * | 1973-12-29 | 1975-07-03 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur herstellung von 3-amino-1,2,4-oxadiazolen |
Non-Patent Citations (1)
Title |
---|
ZEITSCHRIFT FUER CHEMIE 1974, 14(3) pages 94-95. G. WESTPHAL et R.SCHMIDT: "Reaktionen an 3-Amino-1,2,4-oxadiazolen" * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4242352A (en) * | 1977-07-12 | 1980-12-30 | Synthelabo | 3-Amino-5-benzyl-1,2,4-oxadiazoles and anti-hypertensive compositions thereof |
Also Published As
Publication number | Publication date |
---|---|
NZ187825A (en) | 1980-03-05 |
ES478527A1 (es) | 1979-05-16 |
US4242352A (en) | 1980-12-30 |
AU515506B2 (en) | 1981-04-09 |
DE2860691D1 (en) | 1981-08-13 |
AR222310A1 (es) | 1981-05-15 |
GR64924B (en) | 1980-06-09 |
EP0000452B1 (de) | 1981-05-06 |
IL55104A0 (en) | 1978-09-29 |
AU3790978A (en) | 1980-01-17 |
CA1130806A (en) | 1982-08-31 |
DK307378A (da) | 1979-01-13 |
FI782220A (fi) | 1979-01-13 |
PT68267A (fr) | 1978-08-01 |
US4261994A (en) | 1981-04-14 |
IT7825497A0 (it) | 1978-07-10 |
IL55104A (en) | 1982-07-30 |
NO782404L (no) | 1979-01-15 |
AT362367B (de) | 1981-05-11 |
IT1096906B (it) | 1985-08-26 |
JPS5834473B2 (ja) | 1983-07-27 |
ES471609A1 (es) | 1979-09-16 |
ATA505378A (de) | 1980-10-15 |
JPS5419978A (en) | 1979-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0003383B1 (de) | 4-Amino-3-Sulfonamido Pyridinderivate | |
FR2673427A1 (fr) | Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant. | |
EP0370901A1 (de) | Zentralnervensystem wirksame Chromanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
EP1560826B1 (de) | Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
EP0373998A1 (de) | Propenonoximether, Verfahren zu dessen Herstellung sowie diese enthaltende Arzneinmittel | |
EP0177392A1 (de) | (Pyridyl-2)-1-piperazine, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung | |
EP0092458A2 (de) | Imidazo(1,2-a)Pyridinderivate, ihre Herstellung und therapeutische Verwendung | |
EP0532410A1 (de) | N-substituierte heterozyklische Derivate als Angiotensin II-Inhibitoren | |
HU191316B (en) | Process for producing (2-oxo-1,2,3,5-tetrahydro-imidazo /2,1-b/ quinazoline)-oxy-lakyl-amides and pharmacutical compositions containing them | |
EP0117771B1 (de) | Imino-2-pyrrolidine, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung | |
EP0000452B1 (de) | 1,2,4-Oxadiazolderivate, ihre Herstellung und Verwendung als Arzneimittel | |
EP0076199B1 (de) | Triazoloquinazolone und deren Salze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zusammensetzungen | |
FR2688781A1 (fr) | Imidazolines n-substituees par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant. | |
EP0086126B1 (de) | Imidazolidin-Derivate, Verfahren zu deren Herstellung und therapeutische Anwendung | |
FR2612517A1 (fr) | Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant | |
EP0348257A2 (de) | (Hetero)Aryl-diazol-Derivate, Verfahren zu deren Herstellung und deren Verwendung in der Therapie | |
EP0079810B1 (de) | 4-Phenyl-quinazolin-Derivate wirksam auf das Zentralnervensystem | |
EP0161143B1 (de) | 1,2,4-Thiadiazine und ihre Salze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Arzneimittel | |
FR2822463A1 (fr) | Derives bicycliques de guanidines et leurs applications en therapeutique | |
FR2615188A1 (fr) | Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant | |
FR2516510A1 (fr) | Derives de la (trimethoxy-3,4,5-cinnamoyl)-1-aminocarbonylethyl-4-piperazine substituee utilisables en pharmacie et procede pour leur preparation | |
EP0106860B1 (de) | Karbonsäureamidguanidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
EP0433163A2 (de) | Verfahren zur Herstellung von Imidazobenzodiazepinen und ihren Salzen | |
EP0280627B1 (de) | N-substituierte alpha-Mercaptomethylbenzenpropanamid-Derivate, ihre Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zusammensetzungen | |
EP0012051A1 (de) | 3-Amino-2,4-dioxo(1H,3H)Chinazoline, Verfahren zu ihrer Herstellung und sie enthaltende therapeutische Zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
17P | Request for examination filed | ||
DET | De: translation of patent claims | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19810630 |
|
REF | Corresponds to: |
Ref document number: 2860691 Country of ref document: DE Date of ref document: 19810813 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: SYNTHELABO |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19820617 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19820630 Year of fee payment: 5 Ref country code: NL Payment date: 19820630 Year of fee payment: 5 Ref country code: DE Payment date: 19820630 Year of fee payment: 5 Ref country code: CH Payment date: 19820630 Year of fee payment: 5 Ref country code: BE Payment date: 19820630 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19830609 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Effective date: 19830620 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19830621 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Effective date: 19830630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19840101 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19840301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19850228 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19881117 |
|
EUG | Se: european patent has lapsed |
Ref document number: 78400026.7 Effective date: 19850610 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |